Adjuvant Immunotherapy in Curative Intent Esophageal Cancer Resection Patients: Real-World Experience within an Integrated Health System.
Hyunjee V KwakKian C BanksYun-Yi HungNathan J AlcasidCynthia J SusaiAshish PatelSimon AshikuJeffrey B VelottaPublished in: Cancers (2023)
Despite promising findings of adjuvant immunotherapy improving the survival of patients with esophageal cancer, real-life practice varies greatly from clinical trials. We found that the majority of patients were unable to complete immunotherapy regimens with no improvement in overall 1-year survival.